TGFB1 and chronic kidney disease: TGF-β increases fibroblast activation and the accumulation of ECM by activating canonical Smad-dependent signaling and non-canonical pathways, including the mitogen-activated protein kinase (MAPK) and PI3K-Akt cascades, and this accelerates renal fibrosis in CKD 85.